echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > China's Tumor NGS First Share of Stone Burning Medicine Goes to the U.S.

    China's Tumor NGS First Share of Stone Burning Medicine Goes to the U.S.

    • Last Update: 2020-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: Stone Medicine is officially listed on NASDAQ, raising about $250 million in IPO and Keystone subscriptionJune 12, 2020, Burning Stone Medicine is officially listed on NASDAQ, with the stock symbol BNRthe issue of 13.5 million American Depositary Shares (ADS) at $16.50 per ADSAt the same time, Lake Bleu Capital has subscribed for a $25 million cornerstone investmentBurning Stone Medicine raised about $250 million in initial public offerings and the simultaneous cornerstone subscriptionExisting shareholders of Burning Stone Medicine have subscribed for a total of $79 million of ADS in the initial public offeringunderwriters for this offering are Morgan Stanley, BofA Securities and Cowen
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.